Shopping Cart
- Remove All
- Your shopping cart is currently empty
AChE/Aβ-IN-1 (compound 32) is a potent, orally active acetylcholinesterase (AChE) inhibitor with an IC50 of 86 nM and an NMDA receptor antagonist targeting the GluN1-1b/GluN2B subunit combination with an IC50 of 3.876 μM. It also impedes Aβ aggregation, exhibits favorable blood-brain barrier permeability, offers neuroprotection, and enhances cognitive and spatial memory in rat models [1].
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | Inquiry | Backorder | |
50 mg | Inquiry | Backorder |
Description | AChE/Aβ-IN-1 (compound 32) is a potent, orally active acetylcholinesterase (AChE) inhibitor with an IC50 of 86 nM and an NMDA receptor antagonist targeting the GluN1-1b/GluN2B subunit combination with an IC50 of 3.876 μM. It also impedes Aβ aggregation, exhibits favorable blood-brain barrier permeability, offers neuroprotection, and enhances cognitive and spatial memory in rat models [1]. |
In vitro | AChE/Aβ-IN-1 (compound 32) inhibits the aggregation of Aβ1-42 (10 μM) at concentrations of 5-20 μM over 48 hours [1]. |
In vivo | Compound 32, designated as AChE/Aβ-IN-1, at a dosage of 10 mg/kg/day administered orally for 7 days, mitigated memory deficits in rats induced by Aβ1-42 and decreased the time spent in the platform area of the Morris Water Maze [1]. |
Molecular Weight | 401.34 |
Formula | C20H25BrN4 |
Storage | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.